Spironolactone NDC 51655-344

Product information

Brand name (proprietary)

Spironolactone

Generic name (nonproprietary)

spironolactone

Active ingredients

Spironolactone — 100 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Northwind Health Company, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 203512

Marketing start

May 27, 2020

Listing expires

Dec 31, 2027

Other FDA classes

Aldosterone Antagonists (Mechanism)

Identifiers

Product ID 51655-344_48eb2ef1-10f5-aa75-e063-6294a90a901fSPL ID 48eb2ef1-10f5-aa75-e063-6294a90a901fSPL set ID ab3090fc-458c-17c1-e053-2995a90a6ffaRxCUI 198222UNII 27O7W4T232

Pharmacologic class

Aldosterone Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655034426 followed by a unit qualifier and the quantity Copy

Package 51655-0344-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 203512

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.